Cdc42 is highlighted as a key regulator of intestinal fibrosis that controls mTOR activation to enhance ECM production and contractile actomyosin cytoskeleton in intestinal myofibroblasts.
Overall, CDC20 exacerbated pulmonary fibrosis by inhibiting fibroblast autophagy via blocking the mTOR signaling pathway, which suggested that targeting CDC20 might hold putative therapeutic effect in IPF.
Ya-Tao Guo, Meng-Chan Zhu, Ru-Yi Li et al.· Cellular Signalling· 0 citations
Findings indicate that endocan is required for the coordinated activation of canonical and non-canonical TGF-β signaling during fibroblast transdifferentiation and suggest its potential involvement in the molecular mechanisms underlying cardiac fibrosis.
Federica Aliquò, Alice Pantano, Giulia Giuffrè et al.· International Journal of Mol...· 0 citations
Findings indicate that PDE4 inhibitors, particularly roflumilast, effectively suppress TGF-β1-induced fibrogenic activation in HIMFs by modulating MRTF/SRF and Smad-dependent pathways, highlighting the value of roflumilast for further preclinical investigation as a potential therapeutic strategy for intestinal fibrosis...
Dongju Lee, Y. Choi, In-Kyung Yoo et al.· International Journal of Mol...· 0 citations
Results indicated that Rab5a-mediated autophagy may regulate the phenotype transition and cell behavior of VSMCs through the activation of the extracellular-regulated kinase 1/2 signaling pathway.
Jin-Yun Tan, Luo-Qi Jia, Weihao Shi et al.· 0 citations
The findings reveal that a select developmental isoform of CASP5 amplifies a key epithelial growth program, peaking in specific cell subsets in the intestinal epithelium to sustain their proliferation during stages critical of intestinal epithelial differentiation and regeneration.
Yuhua Shi, Bao-Sen Jia, Yourae Hong et al.· Journal of Immunology· 0 citations
It is suggested that MAGI2 acts as a negative regulator of myofibroblast differentiation by stabilizing PTEN, whereas PREX2 is aberrantly expressed in the fibrotic milieu, negatively modulating MAGI2, thereby accelerating pulmonary fibrosis.
Yozo Sato, K. Kamio, Yasuhiro Terasaki et al.· American Journal of Physiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.